Abbott Laboratories Resolves Legal Dispute with Diabetes Test-Strip Wholesaler Following $33.4 Million Sanction

Abbott Laboratories has settled a legal dispute with a diabetes test-strip wholesaler that was previously mandated to pay Abbott $33.4 million due to discovery misconduct. This development comes after a federal appeals court validated Abbott’s default victory in September. The agreement marks the conclusion of a contentious legal battle involving the wholesaler’s conduct during the discovery phase of the case. For additional details, visit the original article on Law360.